Importancia de las intervenciones socio-legales en un programa basado en la gestión de casos de patología dual grave: 6 años de experiencia by Haro, Gonzalo et al.
ADICCIONES, 2014 · VOL. 26 NÚM. 4 · PÁGS. 371-372
371
adicciones vol. 26, nº 4 · 2014cartas al editor
The SDPP has observed that only 38.9 % of patients had 
a disability which was recognized by public institutions at the 
time of starting treatment; their average income from social 
benefits was 479 Euros a month and 63.5 % of patients had 
no family support. We had to ask for a global dependency 
evaluation in 22.8% of cases. At the end of the program, 
11.9 % of the patients were admitted to a specific center for 
chronic mental illness. In addition, as a response to our pa-
tients volitional, executive, and/or cognitive functional in-
capacity, the SDPP began legal proceedings for application 
for mental disability in a total of 15.3% of cases, the family 
acting as guardians in 8.8 % of cases, or the competent re-
gional authority (the Valencian Provincial government) in 
the other 6.5 %. This percentage is lower than other psycho-
pathologies such as mental retardation, with rates of 29.7% 
(García Ibáñez, Santacana and Ramo, 1999), 31% in the 
case of institutionalization (Borthwick-Duffy, 1994), schi-
zophrenia with percentages between 22% and 44% (Okai, 
Owen, McGuire, Singh, Churchill, & Hotopf, 2007), or ins-
titutionalization at around 10 % (Uggerby, Nielsen, Correll 
& Nielsen, 2011), although it is worth bearing in mind that 
the specific mental health legislation varies in each country 
and thus affects these figures.
In summary, the typical profile of patients with severe 
dual diagnosis is that of a low income man with schizophre-
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Interest in studying dual diagnosis comorbidity between mental disorders and addictions is increasing, but so far has focused only on epidemiological, clinical and prognostic aspects (Szerman et al, 2013). However, the 
socio-legal needs of these patients must also be assessed, es-
pecially if we are to address the problem using a holistic case 
management approach, as in the case of other serious men-
tal disorders such as schizophrenia (Nordén, Eriksson, Kje-
llgren & Norlander, 2012). The Severe Dual Pathology Program 
(SDPP) at the Provincial Hospital of Castellón Consortium 
(Spain) began in 2008 and so far has treated 293 patients. 
The intervention model is integrated, both medically and 
socially and is based on case management; the inclusion cri-
teria is a score of under 30 on the Global Assessment of Functio-
ning (GAF) scale at admission which must have improved to 
over 50 for the patient to be discharged.
81.2 % of the patients we have treated so far were male, 
and most referrals were made from the Emergency Mental 
Health Unit (32.4 %), followed by the Unit of Addictive Be-
havior (23.5 %), and the Mental Health Units (15 %). The 
most prevalent diagnosis at the time of starting the program 
was schizophrenia (46.8 %), followed by personality disor-
der (11.3 %), schizoaffective disorder (8.5 %), and bipolar 
disorder (7.5 %). The majority of patients were polydrug 
addicts (49.5 %) or addicted to alcohol (27.9 %).
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nia, polydrug addiction, and no family support, whose afflic-
tion first becomes noticed after an emergency situation. It is 
rare for these patients to be evaluated for disability or global 
dependency to others, and indeed the judiciary requires the 
presence of a remarkable degree of mental incapacitation 
for this type of incapacitation to be awarded. Patients with 
severe dual diagnosis are at risk of chronic institutionaliza-
tion, although it is possible to prevent this by: a) improved 
attention to health issues (not only in emergency situa-
tions), and b) the provision of not only economic benefits 
but also of social benefits in the form of recognition of the 
limitations these illnesses place upon these patients and the 
defense of their legal rights by their guardians.
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